1. Home
  2. EIX vs RMD Comparison

EIX vs RMD Comparison

Compare EIX & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edison International

EIX

Edison International

HOLD

Current Price

$70.53

Market Cap

27.5B

Sector

Utilities

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$199.28

Market Cap

30.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EIX
RMD
Founded
1886
1989
Country
United States
United States
Employees
N/A
10600
Industry
Electric Utilities: Central
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.5B
30.0B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
EIX
RMD
Price
$70.53
$199.28
Analyst Decision
Hold
Buy
Analyst Count
13
10
Target Price
$72.09
$292.56
AVG Volume (30 Days)
2.3M
1.2M
Earning Date
04-28-2026
04-30-2026
Dividend Yield
5.17%
1.13%
EPS Growth
248.94
N/A
EPS
1.37
N/A
Revenue
$19,317,000,000.00
N/A
Revenue This Year
N/A
$10.60
Revenue Next Year
$3.17
$7.41
P/E Ratio
$50.41
$25.61
Revenue Growth
9.76
N/A
52 Week Low
$47.73
$198.64
52 Week High
$76.22
$293.81

Technical Indicators

Market Signals
Indicator
EIX
RMD
Relative Strength Index (RSI) 52.46 27.37
Support Level $69.01 $198.64
Resistance Level $75.21 $260.21
Average True Range (ATR) 1.53 5.44
MACD 0.08 -0.99
Stochastic Oscillator 86.15 2.50

Price Performance

Historical Comparison
EIX
RMD

About EIX Edison International

Edison International is the parent company of Southern California Edison, an electric utility that distributes electricity to 5 million customers in a 50,000-square-mile area of Southern California, excluding Los Angeles. Edison Energy owns interests in nonutility businesses that deal in energy-related products and services. In 2014, Edison International sold its wholesale power generation subsidiary Edison Mission Energy out of bankruptcy to NRG Energy.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: